group

The CIRM-funded Alpha Stem Cell Clinics are a network of top California medical centers. The Network specializes in delivering stem cell clinical trials to patients. The key to the Network’s success is the ability to accelerate the delivery treatments to patients through partnerships with patients, medical providers and clinical trial sponsors. These partnerships enable:

  • Patient-centered clinical trials with the highest standards of care and research
  • Strategic collaboration with academic and industry teams developing innovative stem cell therapies
  • Leveraging of resources to promote efficiency, acceleration and increased chances of success

Upcoming Event

5th Annual CIRM Alpha Stem Cell Clinics Network Symposium

CIRM – Leading the New Era of Living Medicines

Friday | May 30, 2020
8:30 A.M.—3:30 P.M.
The Sawyer Hotel

500 J Street, Sacramento, CA  95814
Free and Open to the Public

Learn More (Event Flyer/PDF) »

CURRENTLY ENROLLING – ACTIVE TRIALS

  • Research: Bone Marrow Collection
    Acquisition of Bone Marrow from Normal Volunteers for Research Purposes
     
    Sponsor: National Institutes of Health
    Principal Investigator: Mehrdad Abedi, M.D., Ph.D.
    Contact: Lam Nguyen, CCRP  |  916-734-7517  |  lkng@ucdavis.edu

  • Research: Sickle Cell
    A Phase 1/2, Open-Label, Multicenter, Single-Arm Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease  NCT03653247
    Sponsor: Bioverative
    Principal Investigator: Mehrdad Abedi, M.D., Ph.D.
    Contact: Lam Nguyen, CCRP  |  916-734-7517  |  lkng@ucdavis.edu

  • Research: Hodkins Lymphoma
    A Phase 1, Open Label, Non-randomized, Multi-Center Trial of AB-205 in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation  
    NTC03925935    
    Sponsor: Angiocrine
    Principal Investigator: Mehrdad Abedi, M.D., Ph.D.
    Contact: Randi Derner, CRC |  916-719-7473  |  rderner@ucdavis.edu

  • Research: Hematologic Malignancies
    A Phase 1, Dose Escalation and Expansion Study of Engineered Donor Grafts Derived from Mobilized Peripheral Blood (OrcaGraft), With Single Agent Graft Versus-host Disease Prophylaxis, in Recipients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies 
    NCT03802695
    Sponsor: ORCA
    Principal Investigator: Mehrdad Abedi, M.D., Ph.D.
    Contact: Randi Derner, CRC |  916-719-7473  | rderner@ucdavis.edu
  • Disease: Duchenne Muscular Dystrophy
    A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-2) 
      NCT03406780
    Sponsor: Capricor
    Principal Investigator: Craig McDonald, M.D.
    Contact: Colleen Anthonisen   |   canthonisen@ucdavis.edu 

  • Disease: Kidney Transplant
    Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants
      NCT03363945
    Sponsor: Medeor
    Principal Investigator: Junichiro Sageshima, M.D.
    Contact: Macey Sockolov, CRC or Kathie Howes, CRC  |  916-734-4009  |  khowes@ucdavis.edu, mlsockolov@ucdavis.edu
  • Disease: Nasopharyngeal Carcinoma
    A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
      NCT02578641
    Sponsor: Tessa
    Principal Investigator: Mehrdad Abedi, M.D., Ph.D.
    Contact: Stephanie Lim  |   916-734-0561  |   sllim@ucdavis.edu 

  • Disease: Neutropenia
    NLA101 in Adults Receiving High Dose Chemotherapy for AML (LAUNCH) 
      NCT03301597
    Sponsor: CIRM/NOHLA
    Principal Investigator: Mehrdad Abedi, M.D., Ph.D.
    Contact: Stephanie Lim  |   916-734-0561  |   sllim@ucdavis.edu  

  • Disease: Renal Disease
    Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis 
      NCT03183245
    Sponsor: Cirm/Humacyte
    Principal Investigator: Junichiro Sageshima, M.D.
    Contact: Macey Sockolov, CRC or Kathie Howes, CRC  |  916-734-4009  |  khowes@ucdavis.edu, mlsockolov@ucdavis.edu
  • Disease: Glioblastoma
    Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma 
      NCT03400917
    Sponsor: AIVITA Biomedical
    Principal Investigator: Robert O’Donnell, M.D., Ph.D.
    Contact: Christina Romo   |   crromo@ucdavis.edu    

  • Disease: Muscle Injury
    Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF) 
      NCT03451916
    Sponsor: Pluristem
    Principal Investigator: Mark Lee, M.D.
    Contact: Lam Nguyen, CCRP  |  916-734-7517  |  lkng@ucdavis.edu
  • Disease: Tongue Dysphagia
    Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia
       NCT02838316
    Sponsor: UC Davis/Cook Myosite
    Principal Investigator: Peter Belafsky, M.D., Ph.D.
    Contact: Nogah Nativ   |   nhnativ@ucdavis.edu    

  • Disease: HIV & Non-Hodgkin's lymphoma (HIV-NHL)
    Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant 
      NCT02797470
    Sponsor: CIRM
    Principal Investigator: Mehrdad Abedi, M.D., Ph.D.
    Contact: Deborah Stewart  |  916-703-9118  |   distewart@ucdavis.edu   

  • Disease: Retinopathy
    Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
      NCT01736059
    Sponsor: UC Davis
    Principal Investigator: Susanna Park, M.D., Ph.D.
    Contact: Denise Macias   |  916-734-6303  |  dcmacias@ucdavis.edu    

It you do not see a clinical trial above that matches your interest, please visit CIRM at https://www.cirm.ca.gov/patients, or send an email to AlphaStemCellClinic@ucdavis.edu.